Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease

Neuroimaging is advancing a new definition of Alzheimer's disease (AD). Using imaging biomarkers, clinicians may begin to diagnose the disease by identifying pathology and neurodegeneration in either cognitively impaired or unimpaired adults. This “biomarker-based” diagnosis may allow clinician...

Descripción completa

Detalles Bibliográficos
Autores principales: Stites, Shana D., Milne, Richard, Karlawish, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956938/
https://www.ncbi.nlm.nih.gov/pubmed/29780873
http://dx.doi.org/10.1016/j.dadm.2018.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956938/
https://www.ncbi.nlm.nih.gov/pubmed/29780873
http://dx.doi.org/10.1016/j.dadm.2018.02.006

Ejemplares similares